论文信息 - Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study - 字舞流文

Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

S. Thongprasert | C. Watkins | R. Perng | E. Tan | N. Thatcher | P. Parikh | C. Tsao | N. Botwood | A. Chang | Chih‐Hsin Yang | Domingo E. Ganzon